Copyright © 2012, National Academy of Sciences.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Bookshelf ID: NBK91504PMID: 22553897
Alzheimer's Diagnostic Guideline Validation
Exploration of Next Steps
Workshop Summary
Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders.
Washington (DC): National Academies Press (US); 2012.
ISBN-13: 978-0-309-22554-0ISBN-10: 0-309-22554-X
Excerpt
At the request of the Alzheimer's Association, the Institute of Medicine (IOM) Forum on Neuroscience and Nervous System Disorders planned and hosted a 2-hour public workshop at the 2011 Alzheimer's Association International Conference (AAIC). Held in Paris, France, on July 18, 2011, the session brought together key stakeholders to discuss next steps in the validation of the new diagnostic guidelines for Alzheimer's disease (AD), specifically, the revised guidelines recently proposed in papers by the International Working Group for New Research Criteria for the Diagnosis of Alzheimer's Disease, and three working groups under the auspices of the National Institute on Aging (NIA) and the Alzheimer's Association.
Contents
Rapporteurs: Diana E. Pankevich, Theresa Wizemann, Bruce M. Altevogt
This project was supported by contracts between the National Academy of Sciences and the Alzheimer's Association; AstraZeneca Pharmaceuticals, Inc.; CeNeRx Biopharma; the Department of Health and Human Services' National Institutes of Health (NIH, Contract No. N01-OD-4-2139) through the National Institute of Mental Health, National Institute of Neurological Disorders and Stroke; National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, and National Eye Institute, NIH Blueprint for Neuroscience Research, Eli Lilly and Company; GE Healthcare, Inc.; GlaxoSmithKline, Inc.; Johnson & Johnson Pharmaceutical Research and Development, LLC; Merck Research Laboratories; the National Multiple Sclerosis Society; the National Science Foundation (Contract No. OIA-0753701); the Society for Neuroscience; and Wyeth Research, Inc.
Suggested citation:
IOM (Institute of Medicine). 2012. Alzheimer's Diagnostic Guideline Validation: Exploration of Next Steps: Workshop Summary. Washington, DC: The National Academies Press.
The views presented in this publication are those of the editors and attributing authors and do not necessarily reflect the view of the organizations or agencies that provided support for this project.
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.
- PDF version of this title (221K)
-
Future Opportunities to Leverage the Alzheimer’s Disease Neuroimaging Initiative: Workshop Summary
[ 2011]
Future Opportunities to Leverage the Alzheimer’s Disease Neuroimaging Initiative: Workshop SummaryInstitute of Medicine (US) Forum on Neuroscience and Nervous System Disorders. 2011
-
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
[Alzheimers Dement. 2011]
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH. Alzheimers Dement. 2011 May; 7(3):257-62. Epub 2011 Apr 21.
-
Review Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.
[Neurobiol Aging. 1997]
Review Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.. Neurobiol Aging. 1997 Jul-Aug; 18(4 Suppl):S1-2.
-
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
[Alzheimers Dement. 2011]
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, et al. Alzheimers Dement. 2011 May; 7(3):263-9. Epub 2011 Apr 21.
-
Perspectives from the world's largest Alzheimer's disease research conference: Stockholm, Sweden, July 2002.
[Curr Womens Health Rep. 2002]
Perspectives from the world's largest Alzheimer's disease research conference: Stockholm, Sweden, July 2002.Ward Robinson J, Halderman S. Curr Womens Health Rep. 2002 Oct; 2(5):394-6.
-
Alzheimer's Diagnostic Guideline Validation
Alzheimer's Diagnostic Guideline ValidationBookshelf
-
Appendixes - Changing Health Care Systems and Rheumatic Disease
Appendixes - Changing Health Care Systems and Rheumatic DiseaseBookshelf
-
Workshop Guests - Changing Health Care Systems and Rheumatic Disease
Workshop Guests - Changing Health Care Systems and Rheumatic DiseaseBookshelf
-
Changing Health Care Systems and Rheumatic Disease
Changing Health Care Systems and Rheumatic DiseaseBookshelf
-
Summary Tables - Dietary Reference Intakes for Calcium and Vitamin D
Summary Tables - Dietary Reference Intakes for Calcium and Vitamin DBookshelf
Your browsing activity is empty.
Activity recording is turned off.
See more...